First Solar (FSLR) Q3 2024 earnings summary

Executive summary

• Year-to-date net bookings reached 4.0 GW, with a contracted backlog of 73.3 GW through 2030 and an opportunity pipeline of 81.4 GW, including 23.5 GW at mid-to-late stage.

• Record quarterly production of 3.8 GW, with the Alabama factory commencing operations and Louisiana facility on schedule, raising total installed nameplate capacity to 19.4 GW.

• Q3 2024 diluted EPS was $2.91, with net income of $313 million, impacted by a $50 million Series 7 warranty charge.

• Launched new CuRe product line, advanced perovskite development, and commissioned a new R&D center in Ohio.

• Sent notification letters regarding TOPCon patent infringement and upheld Chinese TOPCon patent validity.

Financial highlights

• Q3 2024 net sales were $887.7 million, down $122 million sequentially but up $87 million year-over-year, with gross margin at 50.2%.

• Q3 2024 net income was $313 million; operating income was $322 million; diluted EPS was $2.91.

• Ended Q3 with $1.3 billion in cash and $582 million in debt; net cash position decreased to $0.7 billion.

• Cash flows used in operations were $54 million for Q3; capital expenditures for the nine months were $1.21 billion.

• Inventories increased to $1.52 billion at Q3 end, up $218 million sequentially.

Outlook and guidance

• 2024 net sales guidance revised to $4.10–$4.25 billion, with volume sold expected at 14.2–14.6 GW.

• Gross margin forecasted at $1.95–$2.00 billion, including $1.02–$1.05 billion in Section 45X tax credits.

• Operating income guidance $1.48–$1.54 billion; EPS guidance narrowed to $13.00–$13.50.

• Capital expenditures forecasted at $1.55–$1.65 billion, reduced from prior guidance.

• Year-end 2024 net cash balance expected between $0.5–$0.7 billion.